Compare AVIR & PSNYW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVIR | PSNYW |
|---|---|---|
| Founded | 2012 | 2017 |
| Country | United States | Sweden |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 399.3M | 398.5M |
| IPO Year | 2020 | 2021 |
| Metric | AVIR | PSNYW |
|---|---|---|
| Price | $5.47 | $6.16 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 286.5K | 86.9K |
| Earning Date | 05-11-2026 | 03-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $351,367,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $79.49 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.78 | $0.19 |
| 52 Week High | $6.45 | $9.08 |
| Indicator | AVIR | PSNYW |
|---|---|---|
| Relative Strength Index (RSI) | 65.57 | 81.18 |
| Support Level | $5.13 | $2.45 |
| Resistance Level | $5.83 | $7.50 |
| Average True Range (ATR) | 0.25 | 0.44 |
| MACD | 0.03 | 0.32 |
| Stochastic Oscillator | 92.78 | 73.35 |
Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.
Polestar Automotive Holding UK PLC is a pure play, premium electric car brand, designing performance cars engineered to excite consumers and drive change. It believes that it defines market standards in design, innovation and sustainability. It is determined to improve society by accelerating the shift to sustainable mobility. The company conducts its business as one operating segment with primary commercial operations in Europe, North America, Asia Pacific and various importer markets. The company generates majority of revenue from United Kingdom.